Manufacturer copay assistance · Kyprolis (J9047) · Amgen
$0/dose · Maximum benefit Up to program maximum — amount varies by insurance coverage · Covers Kyprolis drug cost including deductible, co-insurance, and co-payment
Published terms from the manufacturer. Per-patient eligibility is confirmed at enrollment.
This manufacturer program excludes government insurance. Foundation disease funds are the route instead — status shown as of each fund's last verification.
Run a benefits estimate for Kyprolis — the program's cap applies against the patient share CareCost calculates.
Yes — Amgen SupportPlus Co-Pay Program from Amgen. Eligible patients can pay as little as $0 out-of-pocket for each dose or cycle. Commercial insurance is required; Medicare and Medicaid patients are not eligible.
Eligible patients can pay as little as $0 out-of-pocket for each dose or cycle Maximum benefit: Up to program maximum — amount varies by insurance coverage. Covers Kyprolis drug cost including deductible, co-insurance, and co-payment
Accepted insurance: commercial. Not eligible: medicare, medicaid, government.